The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
Open accessAbstract
Background: Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different countries. This study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and control. Methods: Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online database. Continued data from the Cancer Incidence in Five Continents Time Trends, the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression, and annual average percent changes of breast cancer incidence and mortality were calculated. Association between Human Development Index and breast cancer incidence and mortality were estimated by linear regression. Results: There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in 2020. Its incidence and mortality varied among countries, with the age‐standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran, and the age‐standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South Korea. The peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American countries. As for the trends of breast cancer, the age‐standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America (USA) during 2000‐2012. Meanwhile, the age‐standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom, the USA, and Australia during 2000 and 2015. Conclusions: The global burden of breast cancer is rising fast and varies greatly among countries. The incidence and mortality rates of breast cancer increased rapidly in China and South Korea but decreased in the USA. Increased health awareness, effective prevention strategies, and improved access to medical treatment are extremely important to curb the snowballing breast cancer burden, especially in the most affected countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationObesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Fan, L., Strasser-Weippl, K., Li, J.-J., St Louis, J., Finkelstein, D. M., Yu, K.-D., Chen, W.-Q., Shao, Z.-M., & Goss, P. E. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70567-9 · Cited by 1,397
Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070
Soerjomataram, I., & Bray, F. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00514-z · Cited by 1,012
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Human Development Report 2016 - Human Development for EveryonePreprint
Jahan, S. (2017) · RePEc: Research Papers in Economics · Cited by 833
The effects of China’s universal two-child policy
Zeng, Y., & Hesketh, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31405-2 · Cited by 701
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21557 · Cited by 701
Hori, M., Matsuda, T., Shibata, A., Katanoda, K., Sobue, T., & Nishimoto, H. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv088 · Cited by 595
“Westernizing” Women's Risks? Breast Cancer in Lower-Income Countries
Porter, P. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708307 · Cited by 558
Cancer incidence and mortality projections in the UK until 2035.
Smittenaar, C. R., Petersen, K. A., Stewart, K., & Moitt, N. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.304 · Cited by 495 · cited 1×
“Previous studies have only focused on the comparison of breast cancer burden betweenworld regions or the description in one country [1, 15, 18, 19].”
BackgroundSpectrum of Breast Cancer in Asian Women
Agarwal, G., Pradeep, P. V., Aggarwal, V., Yip, C., & Cheung, P. S. Y. (2007) · World Journal of Surgery · doi:10.1007/s00268-005-0585-9 · Cited by 443
Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M. (2010) · BMJ · doi:10.1136/bmj.c3620 · Cited by 412
Cancer overdiagnosis: a biological challenge and clinical dilemma
Srivastava, S., Koay, E. J., Borowsky, A. D., De Marzo, A. M., Ghosh, S., Wagner, P. D., & Kramer, B. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0142-8 · Cited by 337
Palmer, K. (2011) · Occupational Medicine · doi:10.1093/occmed/kqr127 · Cited by 333
Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
Lei, S., Zheng, R., Zhang, S., Chen, R., Wang, S., Sun, K., Zeng, H., Wei, W., & He, J. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0523 · Cited by 272
Self-citationPrediction of cancer incidence in the Nordic countries up to the year 2020.
Møller, B., Weedon‐Fekjær, H., Hakulinen, T. R., Tryggvadóttír, L., Storm, H. H., Talbäck, M., & Haldorsen, T. (2002) · PubMed · Cited by 264
Trends and predictions to 2020 in breast cancer mortality in Europe
Carioli, G., Malvezzi, M., Rodriguez, T., Bertuccio, P., Negri, E., & La Vecchia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.003 · Cited by 264
El Saghir, N. S., Adebamowo, C. A., Anderson, B. O., Carlson, R. W., Bird, P. A., Corbex, M., Badwe, R. A., Bushnaq, M. A., Eniu, A., Gralow, J. R., et al. (2011) · The Breast · doi:10.1016/j.breast.2011.02.006 · Cited by 237
Pfeiffer, R. M., Webb-Vargas, Y., Wheeler, W., & Gail, M. H. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0098 · Cited by 178
Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., Manraj, S., Finesse, A., Somdyala, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33014 · Cited by 143
Reexamining China's Fertility Puzzle: Data Collection and Quality over the Last Two Decades
Zhang, G., & Zhao, Z. (2006) · Population and Development Review · doi:10.1111/j.1728-4457.2006.00119.x · Cited by 134
Reproductive history and breast cancer risk
Kobayashi, S., Sugiura, H., Ando, Y., Shiraki, N., Yanagi, T., Yamashita, H., & Toyama, T. (2012) · Breast Cancer · doi:10.1007/s12282-012-0384-8 · Cited by 132
Prediction of Cancer Incidence and Mortality in Korea, 2019
Jung, K., Won, Y., Kong, H., & Lee, E. S. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.139 · Cited by 129
Cancer screening in China: The current status, challenges, and suggestions
Cao, M., Li, H., Sun, D., He, S., Yu, Y., Li, J., Chen, H., Shi, J., Ren, J., Li, N., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.017 · Cited by 125
Practical implications of imposing a new world standard population
Bray, F., Guilloux, A., Sankila, R. J., & Parkin, D. M. (2002) · Cancer Causes & Control · doi:10.1023/a:1014344519276 · Cited by 120
Zhang, J., Wang, H., Wang, Z., Du, W., Su, C., Zhang, J., Jiang, H., Jia, X., Huang, F., Ouyang, Y., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5483-9 · Cited by 118
GREEN, M., & Raina, V. (2008) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2008.00191.x · Cited by 93
Parkin, D. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.016 · Cited by 92
Birth Cohort and Calendar Period Trends in Breast Cancer Mortality in the United States and Canada
Tarone, R. E., Chu, K. C., & Gaudette, L. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.251 · Cited by 80
Song, Q.-K., Li, J., Huang, R., Fan, J.-H., Zheng, R.-S., Zhang, B., Zhang, B., Tang, Z.-H., Xie, X.-M., Yang, H.-J., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.10021 · Cited by 79
Self-citationLee, J. H., Yim, S., Won, Y., Jung, K., Son, B. H., Lee, H.-D., Lee, E. S., Yoo, K., Ahn, S. H., Shin, H., et al. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.s.s11 · Cited by 72
Zheng, S., Bai, J., Li, J., Fan, J., Pang, Y., Song, Q., Huang, R., Yang, H., Xu, F., Lü, N., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27513 · Cited by 70
Yip, C. H., Cazap, E. L., Anderson, B. O., Bright, K. L., Caleffi, M. M., Cardoso, F., Elzawawy, A. M., Harford, J. B., Krygier, G., Masood, S., et al. (2011) · The Breast · doi:10.1016/j.breast.2011.02.015 · Cited by 65
Foroozani, E., Ghiasvand, R., Mohammadianpanah, Μ., Afrashteh, S., Bastam, D., Kashefi, F., Shakarami, S., & Dianatinasab, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-78517-6 · Cited by 58
The impact of changes in hormone therapy on breast cancer incidence in the US population
Coombs, N. J., Cronin, K. A., Taylor, R. J., Freedman, A. N., & Boyages, J. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9437-5 · Cited by 54
Vegetables, fruits, fibre and colorectal cancer
Hill, M. J. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200202000-00001 · Cited by 47
Zhang, Q., Liu, L., Wang, F., Mu, K., & Yu, Z. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-368 · Cited by 43
Zhang, Y., Zhou, Y., Mao, F., Yao, R., & Sun, Q. (2020) · 癌症:英文版 · doi:10.1002/cac2.12024 · Cited by 43
The Prevalence and Correlates of Breast Cancer among Women in Eastern China
Yu, Z., Jia, C.-X., Liu, L., Geng, C., Tang, J.-H., Zhang, J., Zhang, Q., Li, Y.-Y., & Ma, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037784 · Cited by 39
Reproductive Variables and Risk of Breast Malignant and Benign Tumours in Yunnan Province, China
Yanhua, C., Geater, A. F., You, J., Li, L., Zhou, S., Chongsuvivatwong, V., & Sriplung, H. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.2179 · Cited by 33
Sun, K. X., Zheng, R., Gu, X., Zhang, S. W., Zeng, H. M., Zou, X. N., Xia, C., Yang, Z., Li, H., Chen, W., et al. (2018) · PubMed · doi:10.3760/cma.j.issn.0253-9624.2018.06.003 · Cited by 28
Self-citationCancer mortality in Europe, 1970–2009: an age, period, and cohort analysis
Rosso, T., Malvezzi, M., Bosetti, C., Bertuccio, P., Negri, E., & Vecchia, C. L. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000282 · Cited by 27
Kim, Y.-Y., Kang, H.-J., Ha, S., & Park, J. H. (2019) · Epidemiology and Health · doi:10.4178/epih.e2019043 · Cited by 8
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Dent, R., McArthur, H., Pusztai, L., Kümmel, S., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2409932 · Cited by 561
Global burden and trends of lung cancer incidence and mortality
Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., Zhang, Z., Gao, T., Zhang, Y., & Li, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002529 · Cited by 441
Self-citationTargeting Breast Cancer: An Overlook on Current Strategies
Iacopetta, D., Ceramella, J., Baldino, N., Sinicropi, M., & Catalano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043643 · Cited by 88
Allahqoli, L., Mazidimoradi, A., Momenimovahed, Z., Rahmani, A., Hakimi, S., Tiznobaik, A., Gharacheh, M., Salehiniya, H., Babaey, F., & Alkatout, I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.921015 · Cited by 64
Metadata
- Authors
- Lei, S., Zheng, R., Zhang, S., Wang, S., Chen, R., Sun, K., Zeng, H., Zhou, J., & Wei, W.
- Venue
- Cancer Communications
- Published
- 2021-08-16
- Volume
- 41
- Issue
- 11
- Pages
- 1183-1194
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W3195237310
- Cited by
- 1,113
- References
- 53
- FWCI
- 58.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.